Context Therapeutics Ownership | Who Owns Context Therapeutics?
Context Therapeutics Ownership Summary
Context Therapeutics is owned by 16.88% institutional investors, 1.18% insiders, and 81.93% retail investors. Bioimpact capital is the largest institutional shareholder, holding 15.45% of CNTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.48% of its assets in Context Therapeutics shares.
CNTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Context Therapeutics | 16.88% | 1.18% | 81.93% |
| Sector | Healthcare Stocks | 232.63% | 10.66% | -143.29% |
| Industry | Biotech Stocks | 382.12% | 10.42% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bioimpact capital | 14.71M | 15.45% | $14.25M |
| Avidity partners management lp | 8.98M | 9.44% | $8.70M |
| Nextech invest | 7.42M | 9.22% | $7.79M |
| Blue owl capital lp | 7.43M | 7.81% | $10.93M |
| Nextech invest | 7.42M | 7.79% | $7.19M |
| Deep track capital, lp | 7.42M | 7.79% | $7.19M |
| Blackrock | 851.70K | 5.33% | $1.71M |
| Great point partners | 4.68M | 4.92% | $4.54M |
| Franklin resources | 4.00M | 4.21% | $5.88M |
| Vanguard group | 3.79M | 3.98% | $5.57M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bioimpact capital | 14.71M | 2.33% | $14.25M |
| Avidity partners management lp | 8.98M | 1.98% | $8.70M |
| Great point partners | 4.68M | 1.87% | $4.54M |
| Nextech invest | 7.42M | 1.26% | $7.79M |
| Nextech invest | 7.42M | 1.09% | $7.19M |
| Blue owl capital lp | 7.43M | 0.82% | $10.93M |
| Caxton | 18.40K | 0.63% | $27.05K |
| Sio capital management | 1.34M | 0.33% | $1.30M |
| Deep track capital, lp | 7.42M | 0.20% | $7.19M |
| Velan capital investment management lp | 100.00K | 0.09% | $96.88K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avidity partners management lp | 8.98M | 1.98% | 1.50M |
| Blackrock | 851.70K | - | 851.70K |
| Vanguard group | 3.79M | 0.00% | 290.88K |
| Renaissance | 508.33K | 0.00% | 188.20K |
| Marshall wace, llp | 35.75K | - | 35.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Driehaus capital management | - | - | -2.26M |
| Nantahala capital management | 37.84K | 0.00% | -1.62M |
| Ally bridge group (ny) | - | - | -1.16M |
| Opaleye management | - | - | -1.11M |
| Allostery investments lp | - | - | -950.17K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Blackrock | 851.70K | - | 851.70K | $1.71M |
| Marshall wace, llp | 35.75K | - | 35.75K | $34.68K |
| Acadian asset management | 16.67K | - | 16.67K | $17.00K |
| Farther finance advisors | 1.50K | - | 1.50K | $2.21K |
| Citigroup | 1.35K | - | 1.35K | $1.98K |
Sold Out
| Holder | Change |
|---|---|
| Jpmorgan chase | -80.00 |
| Wells fargo & company/mn | -116.00 |
| Barclays | -167.00 |
| Advisornet financial | -200.00 |
| Federation des caisses desjardins du quebec | -400.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | -72.97% | 16,071,417 | -76.70% | 16 | 0.32% | 3 | -75.00% | 3 | -57.14% |
| Sep 30, 2025 | 5 | -87.18% | 3,733,804 | -94.56% | 3 | 0.08% | 3 | -76.92% | - | -100.00% |
| Jun 30, 2025 | 39 | -9.30% | 68,619,080 | -3.91% | 72 | 1.28% | 12 | 20.00% | 9 | -35.71% |
| Mar 31, 2025 | 9 | -82.69% | 31,512,715 | -56.71% | 33 | 0.40% | - | -100.00% | 1 | -91.67% |
| Dec 31, 2024 | 52 | 23.81% | 72,787,034 | 28.41% | 90 | 1.82% | 28 | 33.33% | 12 | 20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 3.12M | 3.48% | -6.75K |
| Vanguard Total Stock Mkt Idx Inv | 2.82M | 3.06% | - |
| Franklin Biotechnology Discv A(acc)USD | 2.52M | 2.75% | - |
| Franklin Biotechnology Discovery A | 1.48M | 1.61% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 520.90K | 0.57% | - |
| Calamos Market Neutral Income A | 277.81K | 0.30% | - |
| Belfund SICAV Belinvest Equity A USD Acc | 260.00K | 0.28% | - |
| Fidelity Extended Market Index | 248.35K | 0.27% | -479.00 |
| BlackRock Extended Equity Market K | 104.84K | 0.14% | -45.00 |
| Blackrock Extended Mkt Fund CF | 120.30K | 0.13% | 120.30K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 09, 2025 | Lehr Martin A. | Chief Executive Officer | Buy | $70.08K |
| Jun 06, 2025 | Levit Alex C. | Chief Legal Officer, Corp. Sec | Buy | $11.52K |
| Jun 06, 2025 | Minai-Azary Jennifer Lynn | Chief Financial Officer | Buy | $25.49K |
| Feb 21, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
| Feb 13, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 3 | - |
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
CNTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools